IL-1β Levels During MS Remission May Predict Progression
A study of 170 patients with relapsing-remitting MS found that detectable levels of IL-1β in cerebrospinal fluid may help predict disease progression
A study of 170 patients with relapsing-remitting MS found that detectable levels of IL-1β in cerebrospinal fluid may help predict disease progression
Detection of interleukin-1β in cerebrospinal fluid during periods of remission appears to be a...
Clinical Research